Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex
- PMID: 12161410
- DOI: 10.1093/jac/dkf137
Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex
Abstract
The Burkholderia cepacia complex is a diverse group of human pathogens that cause life-threatening lung infections in patients with cystic fibrosis or chronic granulomatous disease, and in patients requiring intensive care. Most previous antimicrobial susceptibility studies of these bacteria were performed before recent major revisions in the taxonomy of these bacteria. We determined the in vitro susceptibility of 65 B. cepacia complex isolates from clinical and environmental sources, representing six genomovars. Although intrinsic resistance is considered to be a common feature of the B. cepacia complex, MICs of individual antimicrobials varied widely and resistance was not exhibited by all members of the group.
Similar articles
-
Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media.J Appl Microbiol. 2003;95(6):1191-9. doi: 10.1046/j.1365-2672.2003.02054.x. J Appl Microbiol. 2003. PMID: 14632991
-
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.J Med Microbiol. 2017 Apr;66(4):490-501. doi: 10.1099/jmm.0.000458. J Med Microbiol. 2017. PMID: 28463663
-
Advances in Burkholderia cepacia complex.Paediatr Respir Rev. 2002 Sep;3(3):230-5. doi: 10.1016/s1526-0542(02)00185-9. Paediatr Respir Rev. 2002. PMID: 12376059 Review.
-
Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex.FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):87-92. doi: 10.1016/S0928-8244(02)00442-X. FEMS Immunol Med Microbiol. 2003. PMID: 12628542
-
[Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].Ann Biol Clin (Paris). 2001 May-Jun;59(3):259-69. Ann Biol Clin (Paris). 2001. PMID: 11397673 Review. French.
Cited by
-
Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.Antimicrob Agents Chemother. 2016 Sep 23;60(10):6003-12. doi: 10.1128/AAC.00975-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27458217 Free PMC article.
-
Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates.Appl Environ Microbiol. 2002 Dec;68(12):5956-64. doi: 10.1128/AEM.68.12.5956-5964.2002. Appl Environ Microbiol. 2002. PMID: 12450816 Free PMC article.
-
Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3385-96. doi: 10.1007/s10096-012-1707-6. Epub 2012 Aug 2. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22855365
-
Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.Antimicrob Agents Chemother. 2012 Jan;56(1):464-71. doi: 10.1128/AAC.00602-11. Epub 2011 Oct 17. Antimicrob Agents Chemother. 2012. PMID: 22006009 Free PMC article.
-
Novel Guanidine Compound against Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species.Molecules. 2018 May 11;23(5):1158. doi: 10.3390/molecules23051158. Molecules. 2018. PMID: 29751676 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical